Medtronic receives FDA clearance of Stealth AXiS surgical system

Medtronic (MDT) announced U.S. FDA clearance of the Stealth AXiS surgical system, a next-generation platform that brings planning, navigation, and robotics together into a single, intelligent system for spine surgery. The Stealth AXiS system is cleared for spine procedures in the United States, with an underlying architecture designed to support future cranial and ENT applications, pending 510(k) clearance. Built to support a wide range of surgeon preferences, clinical complexity, and care settings, the platform is designed for use across hospitals and ambulatory surgery centers without relying on multiple standalone technologies.